(1) Responses of bovine adrenal capillary endothelial cells (BACE) on treatment with transforming growth factor beta 1 (TGF-beta 1) have been characterized and tested for sensitivity to inactivation of pertussis toxin-sensitive G-proteins.
(2) Analysis of p34cdc2 activity in BACE cells revealed potent inhibition of p34cdc2 histone H1 kinase activity by TGF-beta 1.
(3) Angiogenin modulates mitogenic stimuli in bovine adrenal capillary endothelial (BACE), rat aortic smooth muscle (RASM), and fibroblast (3T3) cells.
(4) Further investigation revealed that pertussis toxin treatment of BACE cells had no effect on TGF-beta 1-stimulated elevation of steady state mRNA levels for collagen type 1 (alpha 1(1) or alpha 2(1)) or for TGF-beta 1.
(5) The addition of SP to serum-free cultured endothelial cells, isolated from bovine adrenals (BACE) and from human umbilical cord veins (HUVE), increased proliferation of both cell lines in a concentration-dependent manner with maximal activity at 10(-8) M (BACE) and 10(-10) M (HUVE).
(6) Pertussis toxin treatment enhanced both inhibition of BACE cell [3H]methylthymidine uptake and remodeling of BACE monolayers by TGF-beta 1.
(7) TGF-beta 1 elicited growth inhibition, monolayer remodeling, elevation of steady state mRNA levels for collagen type 1 (alpha 1(1) and alpha 2(1)) and TGF-beta 1, and inhibition of p34cdc2 histone H1 kinase activity in BACE cells.
(8) Consistent with suppression of p34cdc2 activation, pertussis toxin also caused substantial inhibition of mitogen-stimulated BACE cell [3H]methylthymidine uptake.
(9) Thus, it enhances the mitogenic effect of certain conditioned media on RASM and 3T3 cells, but it inhibits the mitogenic effect on BACE cells.
Tace
Definition:
(n.) The cross, or church, of St. Antony. See Illust. (6), under Cross, n.
(n.) See Tasse.
Example Sentences:
(1) Sixty-six consecutive patients with unresectable hepatocellular carcinoma (HCC) were treated with transcatheter arterial chemoembolization (TACE) using aclarubicin microspheres (ACRms) in combination with cisplatin suspended in iodized oil (Lipiodol, Laboratoire Guerbert, Paris, France) (CSL).
(2) A reduction of the tumor size after L-TACE did not necessarily mean a good prognosis for the patients.
(3) We investigated the incidence and endoscopic features of gastroduodenal lesions which appeared after transcatheter arterial chemo-embolization (TACE), performed 29 times in 25 patients with inoperative hepatocellular carcinoma.
(4) The single oral dose of quinestrol showed efficacy equal to the 2-day regimen of Tace.
(5) Therefore, we would like to recommend, TACE of HCC in well-selected patients presenting with good clinical status, patency of the portal vein and without broken capsule, in order to achieve better clinical results.
(6) 3) When ADM was dissolved in Gd-DTPA and intraarterially infused without being mixed with lipiodol, the intensity of the signal on MRI was the same as that in LP-TACE immediately after the administration, and gradually decreased thereafter.
(7) The results demonstrated that TACE can be effective for humoral hypercalcemia of HCC.
(8) These results suggest that TACE is more effective than oral chemotherapy for treatment of hepatocellular carcinoma that recurs after partial hepatectomy.
(9) Further follow-up studies will be needed to discover the effects of oral chemotherapy after L-TACE.
(10) The new development or exacerbation of the gastroduodenal lesions after TACE was evident in 13 of the 29 (45%).
(11) In 22% of the HCC patients and in 42% of the metastatic liver cancer patients, the tumor size was reduced by more than 50% after L-TACE.
(12) Transcatheter arterial chemoembolization (TACE) is one of the established therapeutic modalities for treatment of metastatic liver cancer originating in the gastrointestinal tract.
(13) The factors relating to the duration of survival were analyzed for 329 cases of hepatocellular carcinoma (HCC) treated by transcatheter arterial chemoembolization (TACE) between January 1, 1983, and December 31, 1990.
(14) The marked antiestrogen character of TACE was surprising since TACE has been classified and clinically used as an estrogen.
(15) In light of these events, upper gastrointestinal endoscopy should be added to the usual examinations done for patients undergoing TACE.
(16) Cis-Diamminedichloroplatinum (CDDP)-lipiodol suspension (CLS) was developed as a transarterial chemoembolization (TACE) material.
(17) The materials were then clinically prescribed as an embolic agent in preoperative TACE for patients with locally advanced breast cancer.
(18) Under adequate medical care, TACE can safely be applied, although there are some reports about fatal complications.
(19) The survival rates of the HCC patients after L-TACE did not change as a result of oral 5-fluorouracil administration.
(20) TAM and TACE acted as partial agonists on PRL and uterine weight induction.